ARTICLE | Translation in Brief
Mining marine metabolites
Sirenas, BMS use AI to discover small molecule microbiome metabolites
March 22, 2018 12:21 AM UTC
Bristol-Myers Squibb Co. (NYSE:BMY) is tapping Sirenas LLC’s AI platform Atlantis to discover microbiome metabolites for immuno-oncology.
Atlantis applies data mining, computational modeling and machine learning technology to screen microbiome-derived metabolites against cellular and biochemical disease models, which then become the basis for synthetic chemistry campaigns to yield immuno-modulatory candidates...